Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice! Thank you for that Darth. Charlotte's Web is a trailblazer in the industry.
Just to go apples to apples, yes, the coca plant itself is also schedule 2. That goes for the opium poppy plant as well...
"§ 1308.12 Schedule II.":
(3) Opium poppy and poppy straw.
(4) Coca leaves (9040) and any salt, compound, derivative or preparation of coca leaves (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include:
(i) Decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine; or
(ii) [123I]ioflupane.
(5) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy), 9670.
Pretty low bar..."a topical local anesthetic for the upper respiratory tract."...that's all...
Cocaine is a Schedule II drug under the Controlled Substances Act, meaning it has a high potential for abuse and has an accepted medical use for treatment in the United States. Cocaine hydrochloride solution (4 percent and 10 percent) is used primarily as a topical local anesthetic for the upper respiratory tract.
The extremely limited medical uses of cocaine are enough to let it be schedule 2, even with it's extremely high potential for abuse, and there are no state medical cocaine programs. 90% of U.S. states have MMJ programs. Cannabis has a similar dependence potential as caffeine, but caffeine can be lethal...
https://commons.wikimedia.org/wiki/File:Drug_danger_and_dependence.svg
The dorks bullshitted on weed for the last 2 years so they could save it as a carrot to dangle in front of voters for midterms lol. What is or is not a schedule one substance by definition should have nothing to do with who wins anything...
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
FDA has approved Epidiolex, which contains a purified form of the drug substance cannabidiol (CBD) for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients 2 years of age and older. That means FDA has concluded that this particular drug product is safe and effective for its intended use.
The agency also has approved Marinol and Syndros for therapeutic uses in the United States, including for nausea associated with cancer chemotherapy and for the treatment of anorexia associated with weight loss in AIDS patients. Marinol and Syndros include the active ingredient dronabinol, a synthetic delta-9- tetrahydrocannabinol (THC) which is considered the psychoactive intoxicating component of cannabis (i.e., the component responsible for the “high” people may experience from using cannabis). Another FDA-approved drug, Cesamet, contains the active ingredient nabilone, which has a chemical structure similar to THC and is synthetically derived. Cesamet, like dronabinol-containing products, is indicated for nausea associated with cancer chemotherapy.
FDA is aware that unapproved cannabis and/or unapproved cannabis-derived products are being used to treat a number of medical conditions including, AIDS wasting, epilepsy, neuropathic pain, spasticity associated with multiple sclerosis, and cancer and chemotherapy-induced nausea.
States/Territories with Medical Marijuana Laws
Alaska Alabama Arizona
Arkansas California CNMI
Colorado Connecticut Delaware
District of Columbia Florida Guam
Hawaii Illinois Louisiana
Maine Maryland Massachusetts
Michigan Minnesota Mississippi
Missouri Montana Nevada
New Hampshire New Jersey New Mexico
New York North Dakota Ohio
Oklahoma Oregon Pennsylvania
Puerto Rico Rhode Island South Dakota
Utah Vermont Virginia
Virgin Islands Washington West Virginia
Current Assignee: US Department of Health and Human Services
Status: Expired - Lifetime
Bloomberg's Shea said that if the Democrats hold a majority in Congress after the midterms, progress toward legalization is a plausible scenario followed by "a subsequent rush of equity capital markets activity."
#DDAmanda Chart on: $NWBO :
You can scan for these before they run. #DDAmanda works.
#DDAmanda Halloween Special: https://ddamanda.com/SignUpHalloween175.php
#DDAmanda is still the best way to find #WinningStocks before they run.
Contact/Text: 760 702-2009
Trial Subscription($8): https://www.ddamanda.com/SignUpDaily.php
What the Fact (Factor) Column is:
The Factor is a proprietary indicator used for scanning in #DDAmanda.
It's defined as Today's $Traded divided by the average daily $Traded (20 day avg).
SO, if a stock has say a 10 Factor that day, it means she traded 10 Times the $ she normally trades.
That's significant, and many times indicates that a run in the stock is coming.
Endexx Highlights Fiscal Fourth Quarter 2022 Accomplishments
$EDXC - Endexx Corporation reviews key accomplishments over the Company’s fiscal fourth quarter ahead of financial reporting.
Highlights include:
Blesswell™ men’s skincare line introduced first in Target stores and then on Amazon.com. Following Endexx’s CBD pain products availability at Walgreens and skincare at CVS , Endexx products are now available in four of the top eight retailers in the United States in over 8000 mass retail stores nationwide.
Amazon distribution of Blesswell™ skin care products expanded beyond the United States to 13 countries, including Australia, Belgium, Canada, France, Germany Italy, Japan, Mexico, Netherlands, Poland, Spain, Sweden, and the United Kingdom
Endexx significantly expanded its international distribution network and potential revenue streams though the controlling interest acquisition of HYLA, a non-nicotine, guarana-based vape product available in Germany, Italy, Israel, Egypt, Slovenia, Romania, Iran and Bahrain, the United States (where the HYLA formulations are produced) Canada, the Czech Republic, Georgia, Russia, Slovakia, South Africa, Switzerland, the United Arab Emirates, the United Kingdom, and Uzbekistan
Endexx strengthened its balance sheet by entering into the settlement, lock-up, and leak-out agreements with its Historic Investors, in which each Historic Investor agreed to exchange its pre-acquisition Convertible Note and Warrants with a replacement simple Promissory Note. This new Historic Investor Replacement Note removed the convertible debt and warrants and replaced by a simple, non-convertible debt facility with an 18-month term.
HYLA secured two new purchase orders exceeding 200,000 units in the first month of joining Endexx.
https://finance.yahoo.com/news/endexx-highlights-fiscal-fourth-quarter-120000947.html
Historic cannabis news!...Major League Baseball and $CWBHF...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170173327
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170175588
Canopy Growth Corporation $CGC who's buying their stock shares? https://finance.yahoo.com/quote/CGC/holders?p=CGC
Aurora Cannabis Inc. $ACB Who's buying? https://finance.yahoo.com/quote/ACB/holders?p=ACB
Sundial Growers $SNDL whos buying? https://finance.yahoo.com/quote/SNDL/holders?p=SNDL
Canopy Growth Corporation $CGC Top Institutional Holders
Holder Shares Date Reported % Out Value
Vanguard Group, Inc. (The) 8,099,679 Jun 29, 2022 1.69% 20,208,698
ETF Managers Group, LLC 7,856,049 Jun 29, 2022 1.64% 19,600,841
Millennium Management Llc 3,152,591 Jun 29, 2022 0.66% 7,865,714
Morgan Stanley 2,839,979 Jun 29, 2022 0.59% 7,085,747
Bank of America Corporation 2,057,707 Jun 29, 2022 0.43% 5,133,978
Two Sigma Investments, LP 1,862,092 Jun 29, 2022 0.39% 4,645,919
Bank of Montreal/Can/ 1,721,627 Jun 29, 2022 0.36% 4,295,459
Shaw D.E. & Co., Inc. 1,197,214 Jun 29, 2022 0.25% 2,987,048
Ameriprise Financial, Inc. 1,196,406 Jun 29, 2022 0.25% 2,985,032
Two Sigma Advisers, LP 1,157,100 Jun 29, 2022 0.24% 2,886,964
Top Mutual Fund Holders
Holder Shares Date Reported % Out Value
ETF Managers Tr-EFTMG Alternative Harvest ETF 7,856,049 Jun 29, 2022 1.64% 19,600,841
Vanguard International Stock Index-Total Intl Stock Indx 3,249,463 Jul 30, 2022 0.68% 8,107,409
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 1,772,589 Jun 29, 2022 0.37% 4,422,609
Global X Fds-The Global X Cannabis ETF 1,543,348 Aug 30, 2022 0.32% 3,850,653
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index 1,114,799 Jul 30, 2022 0.23% 2,781,423
Spinnaker ETF Tr-Cannabis ETF 489,767 May 30, 2022 0.10% 1,221,968
AdvisorShares Trust-AdvisorShares Pure Cannabis ETF 469,798 Sep 29, 2022 0.10% 1,172,145
Schwab Strategic Tr-Schwab International Small Cap Equity ETF 421,326 May 30, 2022 0.09% 1,051,208
Amplify Seymour Cannabis ETF 445,349 Jul 30, 2022 0.09% 1,111,145
DFA Investment Dimensions-Canadian Small Company Series 313,200 Jul 30, 2022 0.07% 781,433
$ACB Top Institutional Holders
Holder Shares Date Reported % Out Value
ETF Managers Group, LLC 10,526,850 Jun 29, 2022 3.50% 10,947,923
Vanguard Group, Inc. (The) 7,118,236 Jun 29, 2022 2.37% 7,402,965
Millennium Management Llc 3,274,509 Jun 29, 2022 1.09% 3,405,489
Renaissance Technologies, LLC 3,220,384 Jun 29, 2022 1.07% 3,349,199
Shaw D.E. & Co., Inc. 2,664,650 Jun 29, 2022 0.89% 2,771,235
Two Sigma Investments, LP 2,515,071 Jun 29, 2022 0.84% 2,615,673
Morgan Stanley 2,385,461 Jun 29, 2022 0.79% 2,480,879
Mirae Asset Global Investments Co., Ltd. 1,798,034 Jun 29, 2022 0.60% 1,869,955
Bank of Montreal/Can/ 1,124,549 Jun 29, 2022 0.37% 1,169,530
Dimensional Fund Advisors LP 1,021,516 Jun 29, 2022 0.34% 1,062,376
Top Mutual Fund Holders
Holder Shares Date Reported % Out Value
ETF Managers Tr-EFTMG Alternative Harvest ETF 10,526,850 Jun 29, 2022 3.50% 10,947,923
Global X Fds-The Global X Cannabis ETF 2,921,758 Aug 30, 2022 0.97% 3,038,628
Vanguard International Stock Index-Total Intl Stock Indx 2,682,478 Jul 30, 2022 0.89% 2,789,777
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 1,563,747 Jun 29, 2022 0.52% 1,626,296
DFA Investment Dimensions-Canadian Small Company Series 763,275 Jul 30, 2022 0.25% 793,805
Spinnaker ETF Tr-Cannabis ETF 408,045 May 30, 2022 0.14% 424,366
Schwab Strategic Tr-Schwab International Small Cap Equity ETF 351,932 May 30, 2022 0.12% 366,009
College Retirement Equities Fund-Stock Account 331,029 Jun 29, 2022 0.11% 344,270
Fidelity NASDAQ Composite Index Fund 266,465 Aug 30, 2022 0.09% 277,123
iShares Core MSCI Total International Stock ETF 252,412 Aug 30, 2022 0.08% 262,50
For what it's worth, it is the Federal Government's own cannabis patent, 6630507, that lead many of us industry vets into the first "pot stocks" a decade ago. If they want rescheduling to move fast now, it will, as they really should have removed it from schedule 1 status as soon as they were assigned that patent. How long do we think it will take the Department of Health and Human Services to review their own patent LOL?...Expired or not, oddly enough, the patent was granted 19 years ago from today...
"Cannabinoids as antioxidants and neuroprotectants":
US-6630507-B1
Publication Date
2003/10/07
Current Assignee
US Department of Health and Human Services
Status
Expired - Lifetime
Abstract
Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuroprotective antioxidants is formula (I) wherein the R group is independently selected from the group consisting of H, CH3, and COCH3.
U.S. Health and Human Services (HHS) Secretary Xavier Becerra said in Tampa Friday that he intends for his agency to move “as quickly as we can” to comply with President Joe Biden’s directive to review the decades-old policy of listing marijuana as a Schedule I drug.
Actually..."Biden Health Secretary Has Already Talked To FDA About Marijuana Scheduling Review, Which Will Move ‘Quickly’":
October 7, 2022
https://www.marijuanamoment.net/biden-health-secretary-has-already-talked-to-fda-about-marijuana-scheduling-review-which-will-move-quickly/
Just great. So the MORE act will not be be passed anytime soon. They’re going to take their sweet ass time “investigating” why it is a schedule one drug. I can save them a bunch of time
but they already know this. It’s a schedule one because Mr. Rockefeller wanted it to be.
"Justice Department Statement on President’s Announcements Regarding Simple Possession of Marijuana":
October 6, 2022
The Justice Department today released the following statement from spokesman Anthony Coley regarding the President’s proclamation granting a full, complete, and unconditional pardon to U.S. citizens and lawful permanent residents who have committed, or been convicted of, the offense of simple possession of marijuana in violation of the Controlled Substances Act, as currently codified at 21 U.S.C. 844 and as previously codified elsewhere in the U.S. Code, or in violation of D.C. Code 48–904.01(d)(1):
“The Justice Department will expeditiously administer the President’s proclamation, which pardons individuals who engaged in simple possession of marijuana, restoring political, civil, and other rights to those convicted of that offense. In coming days, the Office of the Pardon Attorney will begin implementing a process to provide impacted individuals with certificates of pardon.
“Also, in accordance with the President’s directive, Justice Department officials will work with our colleagues at the Department of Health and Human Services as they launch a scientific review of how marijuana is scheduled under federal law.”